SCHEMBL3528919

SCHEMBL3528919

O=S(=O)(NCC(F)(F)F)c1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.57
ALDH1A1 P00352 6/20 0.55
LMNA P02545 2/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
KEAP1 Q14145 1/20 0.55
KDM4E B2RXH2 1/20 0.55
PKM P14618 1/20 0.55
CA1 P00915 5/20 0.50
CA2 P00918 5/20 0.50
CA12 O43570 4/20 0.50
CA9 Q16790 4/20 0.50
GBA1 P04062 2/20 0.50
NPSR1 Q6W5P4 1/20 0.49
MEN1 O00255 1/20 0.48
POLB P06746 1/20 0.48
KMT2A Q03164 1/20 0.48
IDH2 P48735 2/20 0.47
MMP1 P03956 1/20 0.47
MMP2 P08253 1/20 0.47
MMP9 P14780 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16894131 0.82 ALDH1A1 (0.71) ALDH1A1LMNASMN1; SMN2PKMCA1
SCHEMBL12362794 0.81 ALDH1A1 (0.54) CYP2C19ALDH1A1LMNACA1CA2
SCHEMBL4773915 0.81 CA1 (0.75) CYP2C19ALDH1A1LMNACA1CA2
SCHEMBL3686095 0.81 ALDH1A1 (0.61) ALDH1A1LMNASMN1; SMN2KEAP1KDM4E
SCHEMBL4025712 0.81 CA1 (0.56) ALDH1A1PKMCA1CA2CA12
SCHEMBL3013616 0.81 CA1 (0.51) ALDH1A1CA1CA2CA12CA9
SCHEMBL19011453 0.81 ALDH1A1 (0.61) ALDH1A1SMN1; SMN2CA1CA2CA12
SCHEMBL1018953 0.80 MEP1B (0.58) CYP2C19ALDH1A1CA1CA2CA12
SCHEMBL9577126 0.80 ALDH1A1 (0.68) CYP2C19ALDH1A1LMNASMN1; SMN2KEAP1
SCHEMBL9281374 0.80 CYP2C19 (0.67) CYP2C19ALDH1A1LMNASMN1; SMN2KEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3033342-A1 ANNELATED PYRROLES AND THEIR USE AS CRAC INHIBITORS Grünenthal GmbH (DE) 2016-06-22 EP claimed
WO-2015022073-A1 ANNELATED PYRROLES AND THEIR USE AS CRAC INHIBITORS Grünenthal GmbH (DE) 2015-02-19 WO claimed
EP-4281073-A1 COMBINATION OF A 3-(IMIDAZOL-4-YL)-4-(AMINO)-BENZENESULFONAMIDE TEAD INHIBITOR WITH AN EGFR INHIBITOR AND/OR MEK INHIBITOR FOR USE IN THE TREATMENT OF LUNG CANCER Ikena Oncology, Inc. (US) 2023-11-29 EP disclosed
WO-2022159986-A1 COMBINATION OF A 3-(IMIDAZOL-4-YL)-4-(AMINO)-BENZENESULFONAMIDE TEAD INHIBITOR WITH AN EGFR INHIBITOR AND/OR MEK INHIBITOR FOR USE IN THE TREATMENT OF LUNG CANCER Ikena Oncology, Inc. (US) 2022-07-28 WO disclosed
CN-105102449-B Antiviral compound 豪夫迈·罗氏有限公司 2017-06-13 CN disclosed
EP-3134396-A1 AMINO PYRIDINE DERIVATIVES AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS Novartis AG (CH) 2017-03-01 EP disclosed
CN-105189508-A Cycloalkyl nitrile pyrazolo pyridones as JANUS kinase inhibitors MERCK SHARP & DOHME 2015-12-23 CN disclosed
WO-2015162456-A1 AMINO PYRIDINE DERIVATIVES AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS NOVARTIS AG (CH) 2015-10-29 WO disclosed
WO-2014035872-A1 TRICYCLIC ALKYNES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN AMGEN INC. (US) 2014-03-06 WO disclosed
US-7645771-B2 CCR5 antagonists as therapeutic agents SMITHKLINE BEECHAM CORP. (US) 2010-01-12 US disclosed